Trichuriasis: Clinical Trials

30 trials for Trichuriasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 4 not yet recruiting, 4 recruiting, 1 active not recruiting. 11 Phase 2, 8 Phase 3, 5 Not applicable, 5 Phase 4, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 211Completed 8, Not yet recruiting 2, Recruiting 1
Phase 38Completed 6, Not yet recruiting 2
Not applicable5Completed 3, Active not recruiting 1, Unknown 1
Phase 45Completed 3, Recruiting 1, Withdrawn 1
Phase 12Completed 1, Recruiting 1

Follow Trichuriasis: new trials by email Literature Review of Trichuriasis trials Research Report on Trichuriasis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita
Emodepside, Albendazole 400 mg - Trichuris Infection
Phase 2Not yet recruitingJennifer Keiser1002026-11-152026-08-14
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
emodepside (BAY 44-4400), Mebendazole 100 MG, similar placebo to mebendazole - Trichuris Trichiura; Infection, Hookworm Infection
Phase 3Not yet recruitingSwiss Tropical & Public Health Institute3152026-11-062026-08-14
Combination Therapies for Trichuris Trichiura Infection in Schoolchildren in Honduras
Placebo, Albendazole 400 mg, Albendazole Plus Ivermectin - Trichuriasis, Strongyloidiasis
Phase 3Not yet recruitingMundo Sano Foundation3682026-11-012026-06-23
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Dengue, Chikungunya
RecruitingInstitut Pasteur du Cambodge100002025-12-182026-01-22
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
emodepside (BAY 44-4400), matching placebo of emodepside, Mebendazole - Trichuris Trichiura; Infection, Hookworm Infection
Phase 3CompletedSwiss Tropical & Public Health Institute3152025-11-252026-10-08
Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults
Trichuris trichiura Egg Inoculum - Whipworm, Trichuriasis
Phase 1RecruitingGeorge Washington University182025-09-102026-06-04
Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases
Moxidectin, Ivermectin - Onchocerciasis, Ascaris Lumbricoides Infection
Phase 4RecruitingKirby Institute520002025-08-042025-11-21
Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura
Oxantel Pamoate, Mebendazole - Trichuris Trichiura; Infection, Hookworm Infection
Phase 2CompletedJennifer Keiser1632025-04-162025-06-08
Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate Tablets
Oxantel Pamoate, Placebo - Healthy
Phase 1CompletedSwiss Tropical & Public Health Institute452025-01-272025-08-28
A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults
Albendazole, Oxfendazole - Trichuriasis
Phase 2RecruitingAsociacion Benefica Prisma2492024-09-072026-07-28
Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults
Oxfendazole, Albendazole - Trichuris Infection
Phase 2Not yet recruitingOxfendazole Development Group2502024-07-012023-11-08
Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC
Ivermectin 1.5 mg ODT, Ivermectin 3 mg Oral Tablet, Albendazole 400 mg Oral Tablet - Trichuriasis, Ascariasis
Phase 2CompletedJennifer Keiser2602024-06-052025-09-22
Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC
Moxidectin 2 mg Oral Tablet, Albendazole 400 mg Oral Tablet, Placebo Moxidectin - Trichuriasis, Ascariasis
Phase 3CompletedJennifer Keiser2242024-05-142025-09-19
Efficacy of Ivermectin-albendazole vs Albendazole Alone in School-aged Children Infected With Trichuris Trichiura
IVM (200 µg/kg) + ALB (400 mg), ALB (400mg) - Trichuriasis
Phase 3CompletedJennifer Keiser1612023-10-092024-04-10
Cement flooRs AnD chiLd hEalth (CRADLE)
Concrete household floor - Ascaris Lumbricoides Infection, Necator Americanus Infection
Not applicableActive not recruitingStanford University8002023-09-242026-04-28
Evaluating Impact of Improved Floors on Health
Sealed washable floor plus behaviour change, Behaviour change intervention, Routine deworming - Diarrhoeal Disease, Hookworm Infection
Not applicableCompletedLondon School of Hygiene and Tropical Medicine22002023-04-122025-01-30
Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm
Emodepside - Trichuris Trichiura; Infection, Hookworm Infections
Phase 2CompletedJennifer Keiser4422021-08-022022-05-27
Efficacy and Safety of MOX/ALB Co-administration
Moxidectin 2 mg Oral Tablet, Albendazole 400 mg Oral Tablet, Ivermectin 3 mg Oral Tablet - Trichuriasis, Ascariasis
Phase 3CompletedJennifer Keiser2552021-06-152024-01-24
Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration
moxidectin (8 mg) / albendazole (400 mg), ivermectin (200 µg/kg) / albendazole (400 mg), ALBENDAZOLE 400 Mg ORAL TABLET [ZENTEL] - Trichuriasis, Ascariasis
Phase 2 / Phase 3CompletedJennifer Keiser5362021-03-012024-12-05
Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients
Ivermectin, Albendazole - Trichuris Infection, Helminthiasis
Phase 2CompletedAlejandro Krolewiecki1762019-10-092020-07-29

Showing 20 of 30. Sign in to see all of them.

Narrower conditions

Hookworm Infections (14)  ·  Ancylostomiasis (9)  ·  Ascariasis (8)  ·  Helminthiasis (3)  ·  Diarrhea (2)  ·  Enterobiasis (2)  ·  Neglected Diseases (2)  ·  Strongyloidiasis (2)  ·  Adenoviridae Infections (1)  ·  Arenaviridae Infections (1)  ·  Brucellosis (1)  ·  Bunyaviridae Infections (1)  ·  Caliciviridae Infections (1)  ·  Chickenpox (1)

Broader conditions

Adenophorea Infections (30)  ·  Enoplida Infections (30)  ·  Nematode Infections (30)  ·  Infections (29)  ·  Parasitic Diseases (29)  ·  Helminthiasis (27)  ·  Secernentea Infections (17)  ·  Strongylida Infections (15)  ·  Ascaridida Infections (8)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Skin Diseases, Parasitic (4)  ·  Ectoparasitic Infestations (3)  ·  Skin Diseases (3)  ·  Skin Diseases, Infectious (3)  ·  Skin and Connective Tissue Diseases (3)

Interventions

Albendazole (17)  ·  Ivermectin (8)  ·  Mebendazole (5)  ·  moxidectin (5)  ·  Tablets (4)  ·  emodepside (4)  ·  Bay 44-4400 (2)  ·  oxantel pamoate (2)  ·  oxfendazole (2)  ·  Albumins (1)  ·  Intravital Microscopy (1)  ·  Levamisole (1)  ·  Therapeutics (1)

Sponsors

Jennifer Keiser (10)  ·  Swiss Tropical & Public Health Institute (4)  ·  University Ghent (2)  ·  Alejandro Krolewiecki (1)  ·  Asociacion Benefica Prisma (1)  ·  Centers for Disease Control and Prevention (1)  ·  George Washington University (1)  ·  Institut Pasteur du Cambodge (1)  ·  Kirby Institute (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Mundo Sano Foundation (1)  ·  Natural History Museum, United Kingdom (1)  ·  Oxfendazole Development Group (1)  ·  Oxford University Clinical Research Unit, Vietnam (1)

Countries

Tanzania (11)  ·  Côte d’Ivoire (3)  ·  Argentina (2)  ·  Cambodia (2)  ·  Ethiopia (2)  ·  Honduras (2)  ·  Peru (2)  ·  Vietnam (2)  ·  Angola (1)  ·  Australia (1)  ·  Bangladesh (1)  ·  Brazil (1)  ·  Cameroon (1)  ·  Guatemala (1)  ·  Indonesia (1)

Top investigators

Jennifer Keiser, PhD (2)  ·  Jennifer Keiser, Professor (2)  ·  Alejandro J Krolewiecki, MD, PhD (1)  ·  Alejandro Javier Krolewiecki, PhD, MD (1)  ·  Andrea Graham, PhD (1)  ·  Byron Arana, MD (1)  ·  Charles Mwandawiro, PhD (1)  ·  Claude Flamand, Ph.D. (1)  ·  Daniel Paris, MD, PhD (1)  ·  Gabriela Matamoros, PhD, MSc, BSc (1)  ·  Hussein Mbarak, MD (1)  ·  Jacqueline Leung, MA (1)  ·  Jade Benjamin-Chung, PhD MPH (1)

Results publications

PMID 18775092, PMID 22189084, PMID 25299391, PMID 27266697, PMID 30885157, PMID 31044235, PMID 32405623, PMID 32668456, PMID 33906234, PMID 34191812, PMID 34632308, PMID 34856181, PMID 35217670, PMID 36354034, PMID 37195942, PMID 37195949, PMID 37357904, PMID 38517907, PMID 39108529, PMID 39561184, PMID 39591454, PMID 40032381, PMID 40480665, PMID 40675166, PMID 40975108, PMID 42486129

NIH funding

R01HD108196 (1)